Gaudium IVF & Women Health Limited has filed its Red Herring Prospectus (RHP) for its upcoming Mainboard IPO. The company operates in the healthcare sector with a strong focus on women’s health services and fertility-related treatments, including IVF (In-Vitro Fertilization). This IPO is attracting investor attention because fertility and assisted reproductive technology (ART) services are among the fastest-growing healthcare segments in India.
With increasing awareness, lifestyle changes, delayed marriages, rising infertility rates, and better healthcare access, IVF services have witnessed rapid growth. Gaudium IVF aims to capitalize on this trend by expanding its presence across India and strengthening its fertility healthcare network. Additionally, the company has also been serving international patients, making it a potential beneficiary of India’s growing medical tourism market.
Gaudium IVF IPO 2026 – Key IPO Details
Gaudium IVF & Women Health IPO is a Mainboard Bookbuilding IPO. The issue includes a combination of fresh capital raising and partial stake sale by existing shareholders.
IPO Details
-
Price Band: ₹75 – ₹79 per share
-
Lot Size: 189 shares
-
Issue Size: ₹165.00 crore
-
Face Value: ₹5 per equity share
-
Issue Type: Bookbuilding IPO
-
Listing Platform: NSE & BSE
-
GMP (Rumors): ₹12 (approx. 15.2%) (Last Update 18/02/2026)
The IPO GMP is currently being discussed around ₹12, which indicates positive market sentiment. However, investors should remember that GMP is unofficial and can change quickly depending on subscription trends and market conditions.
IPO Issue Structure (Fresh Issue + OFS)
The Gaudium IVF IPO consists of both Fresh Issue and Offer for Sale (OFS). This means the company will raise new funds through the fresh issue portion, while the OFS allows existing shareholders to sell part of their stake.
Issue Size Breakup:-
-
Total Issue Size: 2,08,86,200 shares (₹165.00 crore)
-
Fresh Issue: 1,13,92,500 shares (₹90.00 crore)
-
Offer For Sale (OFS): 94,93,700 shares (₹75.00 crore)
The presence of a fresh issue is generally considered positive because it strengthens the company’s balance sheet and supports future expansion plans.
Gaudium IVF IPO Timeline (Important Dates)
Here are the important dates for Gaudium IVF IPO 2026:
-
IPO Open Date: February 20, 2026
-
IPO Close Date: February 24, 2026
-
Allotment Date: February 25, 2026
-
Refund Initiation: February 26, 2026
-
Credit of Shares to Demat: February 26, 2026
-
Listing Date: February 27, 2026
This timeline indicates a standard IPO schedule, and investors can expect listing within a few days after the closing date.
Gaudium IVF IPO Lot Size & Investment Amount (Retail/HNI)
The lot distribution and minimum investment amount is an important factor for investors, especially retail applicants.
Retail Category
-
Lots: 1 lot
-
Shares: 189 shares
-
Investment Amount: ₹14,931 (approx.)
-
Reserved Shares: 38,678 lots
Small HNI (sHNI)
-
Lots: 14 lots
-
Shares: 2,646 shares
-
Investment Amount: ₹2,09,034 (approx.)
-
Reserved Shares: 395 lots
Big HNI (bHNI)
-
Lots: 67 lots
-
Shares: 12,663 shares
-
Investment Amount: ₹10,00,377 (approx.)
-
Reserved Shares: 789 lots
This category-based distribution ensures that retail investors can participate with a smaller amount, while HNI investors have the option to apply with larger ticket sizes.
Promoters of Gaudium IVF and Women Health
The promoters of the company mentioned in the RHP are:
-
Dr. Manika Khanna
-
Dr. Peeyush Khanna
-
Vishad Khanna
About Company
Gaudium IVF & Women Health Limited was incorporated in March 2015 and provides a wide range of fertility and women healthcare services across India. The company operates using a hub-and-spoke model, which helps it expand efficiently while ensuring medical quality remains consistent across all locations.
As per the RHP, the company has a network of 30+ locations, including 7 hub centers and 28 spoke centers. The hub centers typically act as major fertility hospitals and advanced IVF centers, while spoke centers help connect patients from smaller regions to the main hub facilities.
The company has also built strong collaborations with infertility experts and doctors to spread awareness regarding ART and IVF treatments. Due to its growing reputation, Gaudium IVF also serves international patients from countries like USA, UK, Canada, Kenya, South Africa, and Oman, making it an emerging player in India’s medical tourism segment.
Key Services Offered
Gaudium IVF provides fertility treatments such as:
-
IVF (In-Vitro Fertilization)
-
ICSI (Intracytoplasmic Sperm Injection)
-
IUI (Intrauterine Insemination)
-
Egg Freezing
-
Ovulation Induction
-
Laser-Assisted Embryo Implantation
It also provides treatment related to women’s health conditions such as:
-
PCOD / PCOS
-
Endometriosis
-
High-risk pregnancy care
-
Male infertility-related support
The company’s facilities are supported by advanced lab infrastructure, including INTEGRA Ti labs for ICSI procedures.
Financial Summary (Restated):-
Below is the financial performance of the company as per the RHP:
| Particulars (₹ Crore) | Sep 30, 2025 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Total Assets | 106.62 | 88.51 | 51.01 | 36.63 |
| Total Income | 49.75 | 70.96 | 48.15 | 44.26 |
| Total Expenses | 32.97 | 45.54 | 31.52 | 25.95 |
| Profit After Tax (PAT) | 12.51 | 19.13 | 10.32 | 13.53 |
IPO Reservation (QIB, NII, Retail)
The IPO reservation is expected to follow SEBI regulations. The RHP states the following reservation structure:
-
QIB (Qualified Institutional Buyers): Up to 50%
-
NII (Non-Institutional Investors): Minimum 15%
-
Retail Individual Investors: Minimum 35%
This structure is standard for mainboard IPOs and ensures participation from both institutions and retail investors.
Key Strengths of Gaudium IVF
Gaudium IVF has multiple business strengths which may support its growth story:
-
Affordable package-based pricing with installment options
-
Strong brand recognition through awareness campaigns
-
Growing demand for fertility and IVF services in India
-
Presence in multiple cities with hub-and-spoke model
-
Rising medical tourism inflow from international patients
-
Advanced lab infrastructure supporting complex fertility procedures
Key Risks & Weaknesses
Like every healthcare company, Gaudium IVF also carries certain operational risks:
-
IVF and fertility procedures involve high medical and operational risks
-
Dependency on skilled embryologists and doctors is high
-
Related party transactions may raise governance concerns
-
Healthcare compliance and regulations can impact operations
-
Business performance may vary based on patient demand and success rates
Investors should always review the RHP carefully and consider risks before investing.
Lead Manager & Registrar
Lead Manager
The IPO is being managed by Sarthi Capital Advisors Private Limited, which has been appointed as the lead manager for this issue.
Registrar
The registrar for the IPO is Bigshare Services Private Limited, responsible for allotment processing and investor-related services.
Company Official Website – https://www.gaudiumivfcentre.com/
Also Read – Shree Ram Twistex IPO RHP Filed: New Mainboard Textile IPO Opens on 23 Feb 2026
Also Read- Razorpay Picks Axis, Kotak, JP Morgan & Citi for 6000 Crore IPO Plan
You Can Also Watch Here